 | Up a level |
2022
Voelk, Stefanie, Pfirrmann, Markus, Koedel, Uwe, Pfister, Hans-Walter, Lang, Thomas, Scheibe, Franziska, Salih, Farid 
ORCID: 0000-0003-1114-3181, Herzig-Nichtweiss, Julia ORCID: 0000-0002-5365-8231, Zimmermann, Julian ORCID: 0000-0003-1964-0078, Alonso, Angelika, Wittstock, Matthias, Totzeck, Andreas, Schramm, Patrick, Schirotzek, Ingo, Onur, Oezguer A., Pelz, Johann Otto, Ottomeyer, Caroline, Luger, Sebastian, Barlinn, Kristian, Binder, Tobias, Woebker, Gabriele ORCID: 0000-0003-4429-754X, Reimann, Gernot, Urbanek, Christian, Heckelmann, Jan, Lochner, Piergiorgio ORCID: 0000-0002-2101-6066, Berghoff, Martin, Schoenenberger, Silvia, Neumann, Bernhard, Niesen, Wolf-Dirk, Dohmen, Christian, Huttner, Hagen B., Guenther, Albrecht and Klein, Matthias
(2022).
Decline in the number of patients with meningitis in German hospitals during the COVID-19 pandemic.
J. Neurol., 269 (7).
S. 3389 - 3400.
HEIDELBERG:
SPRINGER HEIDELBERG.
ISSN 1432-1459
2018
Welte, Tobias, Dellinger, R. Phillip, Ebelt, Henning, Ferrer, Miguel ORCID: 0000-0001-8171-6673, Opal, Steven M., Singer, Mervyn ORCID: 0000-0002-1042-6350, Vincent, Jean-Louis ORCID: 0000-0001-6011-6951, Werdan, Karl, Martin-Loeches, Ignacio, Almirall, Jordi ORCID: 0000-0002-3821-4341, Artigas, Antonio, Ignacio Ayestaran, Jose, Nuding, Sebastian, Ferrer, Ricard ORCID: 0000-0002-4859-4747, Sirgo Rodriguez, Gonzalo, Shankar-Hari, Manu ORCID: 0000-0002-5338-2538, Alvarez-Lerma, Francisco, Riessen, Reimer, Sirvent, Josep-Maria, Kluge, Stefan, Zacharowski, Kai ORCID: 0000-0002-0212-9110, Bonastre Mora, Juan, Lapp, Harald, Woebker, Gabriele, Achtzehn, Ute, Brealey, David, Kempa, Axel, Sanchez Garcia, Miguel, Brederlau, Joerg, Kochanek, Matthias, Reschreiter, Henrik Peer, Wise, Matthew P., Belohradsky, Bernd H., Bobenhausen, Iris, Dalken, Benjamin, Dubovy, Patrick, Langohr, Patrick, Mayer, Monika, Schuettrumpf, Joerg, Wartenberg-Demand, Andrea, Wippermann, Ulrike, Wolf, Daniele and Torres, Antoni ORCID: 0000-0002-8643-2167
(2018).
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).
Intensive Care Med., 44 (4).
S. 438 - 449.
NEW YORK:
SPRINGER.
ISSN 1432-1238